Prostate cancer screening practices and cancer control research (United States)
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Kallioniemi O-P, Visakorpi T (1996) Genetic basis and clonal evolution of human prostate cancer. Advances Cancer Res 68: 225-255.
Stanford JL, Stephenson RA, Coyle LM, et al. Prostate cancer trends 1973-1995. Bethesda, MD: SEER Program, National Cancer Institute.; 1999. Report No.: NIH pub. no. 99-4543.
Hankey BF, Feuer El, Clegg LX, et al. (1999) Cancer surveillance series: interpreting trends in prostate cancer. Part 1: Evidence of the effects of screening in recent cancer incidence, mortality, and survival rates. J Natl Cancer Inst 91: 1017-1024.
Brawley OW (1997) Prostate carcinoma incidence and patient mortality. Cancer 80: 1857-1862.
Howe HL, Wingo PA, Thun MJ, et al. (2001) Annual report to the nation on the status of cancer (1973 through 1988), featuring cancers with recent increasing trends. J Natl Cancer Inst 93: 824-842.
Yatani R, Chigusa I, Akazaki K, et al. (1982) Geographic pathologyof latent prostatic carcinoma. Int J Cancer 29: 611-616.
Stemmermann ON, Nomura A, Chyou P-H, Yatani R (1992) A prospective comparison of prostate cancer at autopsyand as a clinical event: the Hawaii Japanese experience. Cancer Epidemiol Biomarkers Prev 1: 189-193.
Smith DS, Humphrey PA, Catalona WJ (1997) The earlydetection of prostate carcinoma with prostate-specific antigen: the Washington Universityexperience. Cancer 80: 1852-1856.
Bostwick DO, Aquilina JW (1996) Prostatic intraepithelial neoplasia (PIN) and other prostatic lesions as risk factors and surrogate endpoints for cancer chemoprevention trials. J Cellular Biochem 25S: 156-164.
Ayala AG, Czerniak B, Ro JY (2001) Prostate. In: Henson DE, Albores-Saavedra J, eds. Pathologyof Incipient Neoplasia. 3rd ed. New York, NY: Oxford UniversityPress, 2001. pp. 535-569.
Ruijter E, Van de Kaa C, Miller G, et al. (1999) Molecular genetics and epidemiologyof prostate carcinoma. Endocr Rev 20: 22-45.
Zitzelsberger H, Engert O, Walch A, et al. (2001) Chromosomal changes during development and progression of prostate adenocarcinomas. Brit J Cancer 84: 202-208.
Danley KL, Richardson IL, Bernstein L, Langholz B, Ross RK (1995) Prostate cancer: trends in mortalityand stage-specific incidence rates byracial/ethnic group in Los Angeles County, California. Cancer Causes Control 6: 492-498.
Powell IJ (1998) Prostate cancer in the African American: is this a different disease? Sem Urol Oncol 16: 221-226.
Steele CB, Miller DS, Maylahn C, Uhler RJ, Baker CT (2000) Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health 90: 1595-1600.
Morton RA (1994) Racial differences in adenocarcinoma of the prostate in North American men. Urol 44: 637-645.
Satariano WA, Ragland KE, Van den Eeden SK (1998) Cause of death in men diagnosed with prostate carcinoma. Cancer 83: 1180-1188.
Liu L, Cazen W, Bernstein L, Ross RK, Deapen D (2001) Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst 93: 705-709.
Hoffman RM, Gilliland FD, Eley JW, et al. (2001) Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst 93: 388-395.
Jacobsen SJ, Katusic SK, Bergstralh EJ, et al. (1995) Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA 274: 1445-1449.
Morrison AS (1992) Screening in Chronic Disease. New York: Oxford UniversityPress.
Mettlin CJ, Murphy GP, Rosenthal DS, Menck HR (1998) The national cancer data base report on prostate carcinoma after the peak in incidence rates in the U.S. Cancer 83: 1679-1684.
Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK (1993) Prostate cancer screening: what we know and what we need to know. Ann Intern Med 119: 914-923.
American Urological Association (2000) Commentary: prostatespecific antigen (PSA) best practice policy. Oncol 14: 267-286.
Roberts RO, Bergstralh EJ, Katusic SK, Lieber MM, Jacobsen SJ (1999) Decline in prostate cancer mortalityfrom 1980 to 1997 and an update on incidence trends in Olmsted County, Minnesota. Urol 161: 529-533.
Cooney KA, Strawderman MS, Wojno Kl, et al. (2001) Agespecific distribution of serum prostate-specific antigen in a community-based study of African-American men. Urology 57: 91-96.
Heeringa SG, Alcser KH, Doerr K, et al. (2001) Potential selection bias in a community-based study of PSA levels in African-American men. J Clin Epidemiol 54: 142-148.
Dorkin TJ, Neal DE (1997) Basic science aspects of prostate cancer. Sem Cancer BioI 8: 21-27.
Rodriguez C, Tatham LM, Thun MJ, Calle EE, Heath CW (1997) Smoking and fatal prostate cancer in a large cohort of adult men. Am J Epidemiol 145: 466-475.
Colditz GA (1996) Consensus conference: smoking and prostate cancer. Cancer Causes Control 7: 560-562.
Hickey K, Do K-A, Green A (2001) Smoking and prostate cancer. Epidemiol Rev 23: 115-25.
Giovannucci E, Rimm EB, Ascherio A, et al. (1999) Smoking and risk of total and fatal prostate cancer in United States health professionals. Cancer Epidemiol Biomarkers Prev 8: 277-282.
Dai WS, Gutai JP, Kuller LH, Cauley JA (1988) Cigarette smoking and serum sex hormones in men. Am J Epidemiol 128: 796-805.
Field AE, Colditz GA, Willett WC, Longcope C, McKinlay JB (1994) The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormonebinding globulin in middle-aged men. J Clin Endocrinol Metab 79: 1310-1316.
Auvinen A, Rietbergen JB, Denis LJ, Schroder FH, Prorok PC (1996) Prospective evaluation plan for randomized trials of prostate cancer screening. For the International Prostate Cancer Screening Trial Evaluation Group. J Med Screen 3: 97-104.
- Prostate cancer screening practices and cancer control research (United States)
Cancer Causes & Control
Volume 13, Issue 1 , pp 1-5
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Epidemiology, University of Michigan School of Public Health, 109 Observatory Street, Ann Arbor, MI, 48109-2029, USA
- 2. Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
- 3. School of Population Health University of Queensland, Brisbane, Australia